Hospital Acquired Infections Drugs Market - Global Outlook and Forecast 2021-2027

March 2021 | 91 pages | ID: H47DE1B54DBEEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Hospital Acquired Infections Drugs in Global, including the following market information:

Global Hospital Acquired Infections Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Hospital Acquired Infections Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital Acquired Infections Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hospital Acquired Infections Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Hospital Acquired Infections Drugs Market Segment Percentages, By Type, 2020 (%)

• Antibacterial Drugs
• Antiviral Drugs
• Antifungal Drugs

China Hospital Acquired Infections Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Hospital Acquired Infections Drugs Market Segment Percentages, By Application, 2020 (%)

• Urinary Tract Infections
• Ventilator-associated Pneumonia
• Surgical Site Infections
• Bloodstream Infections
• Other Hospital Infections

Global Hospital Acquired Infections Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Hospital Acquired Infections Drugs Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Hospital Acquired Infections Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Hospital Acquired Infections Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Merck
• Pfizer
• Bayer
• GlaxoSmithKline
• Daiichi Sankyo
• AbbVie
• Abbott Laboratories
• Roche
• Jiangsu Hengrui Medicine
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hospital Acquired Infections Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hospital Acquired Infections Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HOSPITAL ACQUIRED INFECTIONS DRUGS OVERALL MARKET SIZE

2.1 Global Hospital Acquired Infections Drugs Market Size: 2021 VS 2027
2.2 Global Hospital Acquired Infections Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hospital Acquired Infections Drugs Players in Global Market
3.2 Top Global Hospital Acquired Infections Drugs Companies Ranked by Revenue
3.3 Global Hospital Acquired Infections Drugs Revenue by Companies
3.4 Top 3 and Top 5 Hospital Acquired Infections Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hospital Acquired Infections Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Acquired Infections Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Hospital Acquired Infections Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hospital Acquired Infections Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Hospital Acquired Infections Drugs Market Size Markets, 2021 & 2027
  4.1.2 Antibacterial Drugs
  4.1.3 Antiviral Drugs
  4.1.4 Antifungal Drugs
4.2 By Type - Global Hospital Acquired Infections Drugs Revenue & Forecasts
  4.2.1 By Type - Global Hospital Acquired Infections Drugs Revenue, 2016-2021
  4.2.2 By Type - Global Hospital Acquired Infections Drugs Revenue, 2022-2027
  4.2.3 By Type - Global Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hospital Acquired Infections Drugs Market Size, 2021 & 2027
  5.1.2 Urinary Tract Infections
  5.1.3 Ventilator-associated Pneumonia
  5.1.4 Surgical Site Infections
  5.1.5 Bloodstream Infections
  5.1.6 Other Hospital Infections
5.2 By Application - Global Hospital Acquired Infections Drugs Revenue & Forecasts
  5.2.1 By Application - Global Hospital Acquired Infections Drugs Revenue, 2016-2021
  5.2.2 By Application - Global Hospital Acquired Infections Drugs Revenue, 2022-2027
  5.2.3 By Application - Global Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Hospital Acquired Infections Drugs Market Size, 2021 & 2027
6.2 By Region - Global Hospital Acquired Infections Drugs Revenue & Forecasts
  6.2.1 By Region - Global Hospital Acquired Infections Drugs Revenue, 2016-2021
  6.2.2 By Region - Global Hospital Acquired Infections Drugs Revenue, 2022-2027
  6.2.3 By Region - Global Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Hospital Acquired Infections Drugs Revenue, 2016-2027
  6.3.2 US Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.3.3 Canada Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.3.4 Mexico Hospital Acquired Infections Drugs Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Hospital Acquired Infections Drugs Revenue, 2016-2027
  6.4.2 Germany Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.4.3 France Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.4.4 U.K. Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.4.5 Italy Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.4.6 Russia Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.4.7 Nordic Countries Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.4.8 Benelux Hospital Acquired Infections Drugs Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Hospital Acquired Infections Drugs Revenue, 2016-2027
  6.5.2 China Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.5.3 Japan Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.5.4 South Korea Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.5.5 Southeast Asia Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.5.6 India Hospital Acquired Infections Drugs Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Hospital Acquired Infections Drugs Revenue, 2016-2027
  6.6.2 Brazil Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.6.3 Argentina Hospital Acquired Infections Drugs Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hospital Acquired Infections Drugs Revenue, 2016-2027
  6.7.2 Turkey Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.7.3 Israel Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.7.4 Saudi Arabia Hospital Acquired Infections Drugs Market Size, 2016-2027
  6.7.5 UAE Hospital Acquired Infections Drugs Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Hospital Acquired Infections Drugs Major Product Offerings
  7.1.4 Merck Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.1.5 Merck Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Hospital Acquired Infections Drugs Major Product Offerings
  7.2.4 Pfizer Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.2.5 Pfizer Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Hospital Acquired Infections Drugs Major Product Offerings
  7.3.4 Bayer Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.3.5 Bayer Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Hospital Acquired Infections Drugs Major Product Offerings
  7.4.4 GlaxoSmithKline Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.4.5 GlaxoSmithKline Key News
7.5 Daiichi Sankyo
  7.5.1 Daiichi Sankyo Corporate Summary
  7.5.2 Daiichi Sankyo Business Overview
  7.5.3 Daiichi Sankyo Hospital Acquired Infections Drugs Major Product Offerings
  7.5.4 Daiichi Sankyo Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.5.5 Daiichi Sankyo Key News
7.6 AbbVie
  7.6.1 AbbVie Corporate Summary
  7.6.2 AbbVie Business Overview
  7.6.3 AbbVie Hospital Acquired Infections Drugs Major Product Offerings
  7.6.4 AbbVie Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.6.5 AbbVie Key News
7.7 Abbott Laboratories
  7.7.1 Abbott Laboratories Corporate Summary
  7.7.2 Abbott Laboratories Business Overview
  7.7.3 Abbott Laboratories Hospital Acquired Infections Drugs Major Product Offerings
  7.4.4 Abbott Laboratories Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.7.5 Abbott Laboratories Key News
7.8 Roche
  7.8.1 Roche Corporate Summary
  7.8.2 Roche Business Overview
  7.8.3 Roche Hospital Acquired Infections Drugs Major Product Offerings
  7.8.4 Roche Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.8.5 Roche Key News
7.9 Jiangsu Hengrui Medicine
  7.9.1 Jiangsu Hengrui Medicine Corporate Summary
  7.9.2 Jiangsu Hengrui Medicine Business Overview
  7.9.3 Jiangsu Hengrui Medicine Hospital Acquired Infections Drugs Major Product Offerings
  7.9.4 Jiangsu Hengrui Medicine Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.9.5 Jiangsu Hengrui Medicine Key News
7.10 Eli Lilly
  7.10.1 Eli Lilly Corporate Summary
  7.10.2 Eli Lilly Business Overview
  7.10.3 Eli Lilly Hospital Acquired Infections Drugs Major Product Offerings
  7.10.4 Eli Lilly Hospital Acquired Infections Drugs Revenue in Global (2016-2021)
  7.10.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hospital Acquired Infections Drugs Market Opportunities & Trends in Global Market
Table 2. Hospital Acquired Infections Drugs Market Drivers in Global Market
Table 3. Hospital Acquired Infections Drugs Market Restraints in Global Market
Table 4. Key Players of Hospital Acquired Infections Drugs in Global Market
Table 5. Top Hospital Acquired Infections Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hospital Acquired Infections Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hospital Acquired Infections Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hospital Acquired Infections Drugs Product Type
Table 9. List of Global Tier 1 Hospital Acquired Infections Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Acquired Infections Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Hospital Acquired Infections Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Hospital Acquired Infections Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Hospital Acquired Infections Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Hospital Acquired Infections Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Hospital Acquired Infections Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Hospital Acquired Infections Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Merck Corporate Summary
Table 31. Merck Hospital Acquired Infections Drugs Product Offerings
Table 32. Merck Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Hospital Acquired Infections Drugs Product Offerings
Table 35. Pfizer Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Bayer Corporate Summary
Table 37. Bayer Hospital Acquired Infections Drugs Product Offerings
Table 38. Bayer Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Hospital Acquired Infections Drugs Product Offerings
Table 41. GlaxoSmithKline Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Daiichi Sankyo Corporate Summary
Table 43. Daiichi Sankyo Hospital Acquired Infections Drugs Product Offerings
Table 44. Daiichi Sankyo Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)
Table 45. AbbVie Corporate Summary
Table 46. AbbVie Hospital Acquired Infections Drugs Product Offerings
Table 47. AbbVie Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)
Table 48. Abbott Laboratories Corporate Summary
Table 49. Abbott Laboratories Hospital Acquired Infections Drugs Product Offerings
Table 50. Abbott Laboratories Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Roche Corporate Summary
Table 52. Roche Hospital Acquired Infections Drugs Product Offerings
Table 53. Roche Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Jiangsu Hengrui Medicine Corporate Summary
Table 55. Jiangsu Hengrui Medicine Hospital Acquired Infections Drugs Product Offerings
Table 56. Jiangsu Hengrui Medicine Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)
Table 57. Eli Lilly Corporate Summary
Table 58. Eli Lilly Hospital Acquired Infections Drugs Product Offerings
Table 59. Eli Lilly Hospital Acquired Infections Drugs Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Hospital Acquired Infections Drugs Segment by Type
Figure 2. Hospital Acquired Infections Drugs Segment by Application
Figure 3. Global Hospital Acquired Infections Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hospital Acquired Infections Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hospital Acquired Infections Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Acquired Infections Drugs Revenue in 2020
Figure 8. By Type - Global Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027
Figure 12. US Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027
Figure 24. China Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Hospital Acquired Infections Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Hospital Acquired Infections Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Merck Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bayer Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GlaxoSmithKline Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Daiichi Sankyo Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. AbbVie Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Abbott Laboratories Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Roche Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Jiangsu Hengrui Medicine Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Eli Lilly Hospital Acquired Infections Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)